| Document Date: 2014-11-18 06:45:56
Open Document File Size: 1,02 MBShare Result on Facebook
City Mesothelin / Helsinki / Frankfurt / IFN / / Company Jäderberg M1 1Oncos Therapeutics Ltd / / Country Germany / Finland / / Event FDA Phase / / Facility Cancer Center / Helsinki University Central Hospital / / MedicalCondition distant metastasis / total tumor / tumor cancer / tumor / patient’s unique cancer / Ovarian cancer / Mesothelioma / tumors / last-line refratory solid tumor / unique cancer / last line solid tumor / metastasis / / MedicalTreatment vaccination / chemotherapy / radiotherapy / surgery / / Organization Helsinki University Central Hospital / 2Docrates Cancer Center / / Position VP / 1x1011 VP / 3x1011 VP / 3x1010 VP / 1x1011 VP / / Product ESO-1 / / Technology Gene Therapy / chemotherapy / / URL www.oncos.com / /
SocialTag |
Tumor-infiltrating lymphocytes (TILs) following intratumoral administration of ONCOS-102 are associated with prolonged overall survival in last line solid tumor patients Pesonen S1, Joensuu T2, Jäger E3, Karbach J3, Wah